|
AGLE
|
Aeglea BioTherapeutics, Inc.
|
US
|
NASDAQ
|
|
AKBA
|
Akebia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AKTX
|
Akari Therapeutics Plc
|
US
|
NASDAQ
|
|
ALBO
|
Albireo Pharma, Inc.
|
US
|
NASDAQ
|
|
ALIM
|
Alimera Sciences, Inc.
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AMAM
|
Ambrx Biopharma Inc.
|
US
|
NYSE
|
|
AMPE
|
Ampio Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
AMRN
|
Amarin Corporation plc
|
US
|
NASDAQ
|
|
AMTI
|
Applied Molecular Transport Inc.
|
US
|
NASDAQ
|
|
ANGN
|
Angion Biomedica Corp.
|
US
|
NASDAQ
|
|
ANNX
|
Annexon, Inc.
|
US
|
NASDAQ
|
|
ANTX
|
AN2 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APGN
|
Apexigen, Inc.
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
APLT
|
Applied Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|